MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.
about
Strategically targeting MYC in cancerThe "virgin birth", polyploidy, and the origin of cancerRegulatory non-coding RNA: new instruments in the orchestration of cell deathTherapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesIdentification of cytotoxic drugs that selectively target tumor cells with MYC overexpressionNew aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cellsMYC on the path to cancerSurvival and death signals can predict tumor response to therapy after oncogene inactivationCDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinomaAberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.Cohesin is required for activation of MYC by estradiol.Oncogene addiction in gliomas: implications for molecular targeted therapyTargeting of the MYCN protein with small molecule c-MYC inhibitorsMyc proteins in brain tumor development and maintenance.Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapyTranscriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors.Noncanonical roles of the immune system in eliciting oncogene addictionMYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cellsUrinary bladder cancer susceptibility markers. What do we know about functional mechanisms?Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.Myc inhibition impairs autophagosome formation.Enigmatic MYC Conducts an Unfolding Systems Biology Symphony.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer.Genome recognition by MYC.Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.The Relationship Between Dormant Cancer Cells and Their Microenvironment.MYC: Master Regulator of Immune Privilege.p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked.Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5.The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomasTargeting MYC-Regulated miRNAs to Combat Cancer.Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database.The downregulation of c-Myc and its target gene hTERT is associated with the antiproliferative effects of baicalin on HL-60 cells.Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
P2860
Q26747745-EFB83F91-DE74-403F-9BD6-0CBB160961DFQ27024916-0EC818AC-8C06-4EE1-A5FD-42A07515B12AQ28066784-283DE62E-64AA-4423-B7E9-9807B24A6C46Q28071309-2EF48FC8-CEC7-4DFE-8065-6E36D5D2F348Q28478132-07E94D8A-643D-4881-BB0D-CFDAE2FC9483Q28534587-97B8516C-1917-4196-A6E3-68B50D5AD154Q29619979-8EBC1194-D4B7-42E6-B5E3-14A082207F0CQ30574736-14507827-04F6-4F82-A8F9-15131D76A667Q34342934-382CB90F-68E8-4870-89A7-805119E0256EQ34443645-3236B38E-DD81-4BEA-8192-DAF09308BE8BQ34474156-879D0FE6-CA98-4CA8-8FD2-39BB73264E63Q35041529-3C61BA89-BA8E-40DA-A99B-D7E1C81410F3Q35173570-1C73BCBC-2B33-4039-9A89-4F030AE17019Q35920494-13ADF14B-FFF8-4393-A359-56DB256D7A75Q36029691-277E10B8-BDBD-4FA2-AAD2-25D34D980577Q36237770-4AC5CCEA-51DA-4CE7-93A3-4340DB985D19Q36683061-469A3C44-58F4-45E8-8FF1-4958C4A78909Q36931816-C2C9E681-EF29-4F2A-A9CA-C3053B1C9066Q36950291-43F99657-7EB1-48EC-9CB0-7FA91F6D373CQ37007328-72AD3C07-5A16-4910-B942-8C9FAE801666Q37327647-E5CF8E30-5A8B-4AAF-93B7-D9E621841C42Q37346986-7F4EDFE4-37CF-4FA2-B6ED-431779624381Q37827073-9D014ADC-7387-4284-8DA5-C7BA929BA8A2Q37833424-862CE51E-0E27-42FA-BFB4-EADCF2E558E7Q38128358-0DCAFFCA-4D90-49DB-9603-7641FC35D45CQ38184910-04B897CF-80D8-43AD-AE70-2D5D87484553Q38592248-8D160A42-FE36-45F0-BC6B-4E5A921E8D1BQ38770676-60BE756F-B9DF-4045-B32F-8760EFE9D94EQ38950549-B15200A9-7362-469C-B7C2-C490C3FE5FCCQ39149130-C5F39033-7192-4CBF-B640-A715FD855367Q40071869-F23B7E3E-C899-4BBC-9A81-E2CBA5C0F91EQ41637362-7D7157BD-2053-44D2-AAA1-4D37F7E81FDCQ42091827-21552F12-A0FC-428E-B381-253DDC0108B4Q42124282-6DCC0E09-5E31-4A57-B2CF-6ABAEA577B98Q42269889-42DEF8DF-7F77-4577-B35F-3691B58FE11CQ42617375-A921187E-261F-430B-8BC3-56208DFB895DQ44924345-44874B0D-D1F4-412D-88D3-2EF47E462D5BQ47116891-D6E82340-4AA1-4F9B-A254-B7866A5B679DQ47797194-65D48A61-BBB4-4DC8-BA3D-E17C60DFC546Q48108703-414BA654-6A83-49EE-B0FB-AF04E5C3930B
P2860
MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@ast
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@en
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@nl
type
label
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@ast
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@en
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@nl
prefLabel
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@ast
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@en
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@nl
P2860
P356
P1433
P1476
MYC Inactivation Elicits Oncog ...... and Host-Dependent Mechanisms.
@en
P2093
Dean W Felsher
P2860
P304
P356
10.1177/1947601910377798
P577
2010-06-01T00:00:00Z